JAYME DAVIS-WADDELL: Open Payments
NPI 1992120075 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,088 in 133 payments from 26 companies in 2025. Trend: 2023 $1,854 · 2024 $2,360 · 2025 $2,088
Food & beverage: $2,088
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $265 |
| PFIZER INC. | 14 | $256 |
| ABBVIE INC. | 9 | $205 |
| Amgen Inc. | 17 | $204 |
| Bayer Healthcare Pharmaceuticals Inc. | 20 | $192 |
| Otsuka America Pharmaceutical, Inc. | 6 | $139 |
| Corcept Therapeutics | 6 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $98 |
| Exact Sciences Corporation | 5 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $70 |
Products named: LEQVIO, NURTEC ODT, Kerendia, VRAYLAR, REXULTI, JARDIANCE, OTEZLA, Korlym.
Industry payments across KY — which companies pay providers there.
